Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vivos Therapeutics Inc (NQ: VVOS ) 2.570 -0.260 (-9.19%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 78,944 Open 2.860 Bid (Size) 2.360 (6) Ask (Size) 2.600 (1) Prev. Close 2.830 Today's Range 2.420 - 2.890 52wk Range 1.910 - 48.79 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Reports Results of Seven-Month Provider-Based Marketing and Distribution Model Pilot June 27, 2024 Via Investor Brand Network InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Strategic Alliance, Private Equity Investment June 12, 2024 Via Investor Brand Network Exposures Product Safety Performance YTD -78.22% -78.22% 1 Month +25.37% +25.37% 3 Month -3.38% -3.38% 6 Month -62.32% -62.32% 1 Year -59.21% -59.21% More News Read More InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q1 2024 Financial Report, Operational Update May 15, 2024 Via Investor Brand Network 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 15, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday May 15, 2024 Via InvestorPlace VVOS Stock Earnings: Vivos Therapeutics Reported Results for Q1 2024 May 14, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's After-Market Session May 14, 2024 Via Benzinga InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Schedules Release of Q1 2024 Results, Conference Call May 14, 2024 Via Investor Brand Network TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Discusses Medicare Reimbursement Approval for CARE Oral Medical Devices in Proactive Interview April 10, 2024 Via Investor Brand Network Topics Product Recall Exposures Legal Product Safety TinyGemsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Achieves Milestone with CARE Oral Medical Devices Gaining Approval for Medicare Reimbursement April 09, 2024 Via Investor Brand Network What's Going On With Vivos Therapeutics Stock? April 09, 2024 Via Benzinga Why Is Laser Photonics (LASE) Stock Up 130% Today? April 09, 2024 Via InvestorPlace Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today? April 09, 2024 Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 09, 2024 Via InvestorPlace Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket April 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session April 01, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 01, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session March 29, 2024 Via Benzinga VVOS Stock Earnings: Vivos Therapeutics Misses EPS, Misses Revenue for Q4 2023 March 28, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session March 28, 2024 Via Benzinga InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Schedules Release of Q4 and FY 2023 Results, Conference Call March 28, 2024 Via Investor Brand Network 12 Health Care Stocks Moving In Friday's Pre-Market Session March 15, 2024 Via Benzinga InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Exercise of Warrants for ~$4M February 15, 2024 Via Investor Brand Network 12 Health Care Stocks Moving In Thursday's Pre-Market Session February 15, 2024 Via Benzinga InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Highlights Favorable Market Developments Creating New Opportunities February 13, 2024 Via Investor Brand Network Topics Product Recall Exposures Legal Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
